Logo

American Heart Association

  5
  0


Final ID:

New outcome metrics for hemorrhagic stroke: What large core trials can teach us about the future of ICH trials

  • Jovin, Tudor  ( Cooper Neurological Institute , Haddonfield , New Jersey , United States )
  • Author Disclosures:
    Tudor Jovin: DO have relevant financial relationships ; Ownership Interest:Route92:Active (exists now) ; Ownership Interest:Viz.ai:Active (exists now) ; Consultant:Contigo Medical:Active (exists now) ; Research Funding (PI or named investigator):Stryker:Past (completed) ; Research Funding (PI or named investigator):Medtronic:Past (completed) ; Consultant:Johnson&Johnson :Active (exists now) ; Ownership Interest:NTI:Active (exists now) ; Ownership Interest:Basking :Active (exists now) ; Ownership Interest:Galaxy:Active (exists now) ; Ownership Interest:Kandu:Active (exists now) ; Ownership Interest:AptaTargets:Active (exists now) ; Ownership Interest:Anaconda:Active (exists now) ; Ownership Interest:Methinks:Active (exists now) ; Ownership Interest:FreeOx Biotech:Active (exists now)
Meeting Info:
Session Info:

Treatment of Spontaneous Severe Deep Intracerebral Hemorrhage

Thursday, 02/06/2025 , 04:45PM - 05:45PM

ISC Invited Symposium

More abstracts from these authors:
Pro: Thrombectomy for ALL LVO within 24hours

Jovin Tudor, Ribo Marc

Mechanical Thrombectomy Considerations for Acute Ischemic Stroke with Ventricular Assist Devices

Jovin Tudor, Todo Kenichi, Park Min, Ooi Yinn Cher, Abdalkader Mohamad, Nguyen Thanh, Chou Sherry

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)